ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Pfizer Considers Its Options In Kalamazoo

January 8, 2007 | APPEARED IN VOLUME 85, ISSUE 2

[+]Enlarge
Credit: Bayer
8502busconbayer.jpg
Credit: Bayer

Pfizer will look for alternatives for a research facility in Kalamazoo, Mich., after the Western Michigan University Foundation withdrew from a deal to buy the site. WMUF had agreed to pay $3.8 million for the building, which was to be used for faculty research and to house private-sector firms, but it determined the estimated $1.5 million to $2 million annual operating cost would be prohibitively expensive. The facility, which sits on one of three campuses in Kalamazoo County that came to Pfizer through its 2003 acquisition of Pharmacia, received a $35 million investment in the late 1990s. A spokesman says the company's options are to sell, donate, mothball, or demolish the site.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment